Cephalosporin prodrug

Cephalosporin prodrugs are chemically modified forms of cephalosporin antibiotics designed to improve oral bioavailability, stability, or other pharmacokinetic properties[2][6]. These prodrugs contain modifications such as ester groups at various positions or β-lactamase-cleavable motifs that are metabolized in vivo to release the active cephalosporin antibiotic[4][6]. Examples include cefpodoxime, cefditoren, and experimental compounds combining cephalosporins with other antibiotics like ciprofloxacin[4]. The prodrug strategy enhances drug delivery but the molecules themselves are not therapeutic targets—rather, they are drugs that target penicillin-binding proteins in bacteria[2].

Other names

Cephalosporin ester prodrugsβ-lactamase-activated cephalosporin prodrugsOral cephalosporin prodrugs

Cephalosporin prodrugs are converted to active cephalosporins, which then inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins[2]